-
公开(公告)号：US11479552B2
公开(公告)日：2022-10-25
申请号：US17376452
申请日：2021-07-15
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yu Yoshida , Yoichi Kita , Makoto Kotake , Keiichi Sorimachi , Toshiyuki Ohfusa , Takafumi Motoki , Taro Asaba
IPC: C07D401/14 , C07D471/08
Abstract: Provided are compounds represented by the following formulas (I), (II), (III) and (IV) having orexin type 2 receptor-activating activity, or their pharmaceutically acceptable salts.
-
2.发明授权Methods and compounds useful in the synthesis of orexin-2 receptor antagonists 有权用于合成食欲肽-2受体拮抗剂的方法和化合物公开(公告)号：US09416109B2
公开(公告)日：2016-08-16
申请号：US14379063
申请日：2013-02-14
Applicant: Eisai R&D Management Co., Ltd.
Inventor： George Anthony Moniz , Annie Zhu Wilcoxen , Farid Benayoud , Jaemoon Lee , Huiming Zhang , Taro Terauchi , Ayumi Takemura , Yu Yoshida , Toshiaki Tanaka , Keiichi Sorimachi , Yoshimitsu Naoe , Yuji Kazuta
IPC: C07D239/34 , C07C69/16 , C07C309/66 , C12P7/22 , C07C309/73 , C07D401/12 , C07C303/28 , C07C29/147
CPC classification number: C07C309/73 , C07B2200/07 , C07C29/147 , C07C69/16 , C07C303/28 , C07C303/44 , C07C309/66 , C07C2601/02 , C07D239/34 , C07D401/12 , C12P7/22 , C07C33/50
Abstract: The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists.
Abstract translation: 本公开提供了可用于制备可用作食欲素-2受体拮抗剂的化合物的化合物和方法。
-
Patent Agency Ranking
公开(公告)号：US20180044285A1
公开(公告)日：2018-02-15
申请号：US15791814
申请日：2017-10-24
Applicant: Eisai R&D Management Co., Ltd.
Inventor： George Anthony Moniz , Annie Zhu Wilcoxen , Farid Benayoud , Toshiaki Tanaka , Keiichi Sorimachi
IPC: C07C309/73 , C12P7/22 , C07C309/66 , C07C303/28 , C07C33/50 , C07D239/34 , C07D401/12 , C07C69/16 , C07C303/44 , C07C29/147
CPC classification number: C07C309/73 , C07B2200/07 , C07C29/147 , C07C69/16 , C07C303/28 , C07C303/44 , C07C309/66 , C07C2601/02 , C07D239/34 , C07D401/12 , C12P7/22 , C07C33/50
Abstract: The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists.
-
公开(公告)号：US20140371319A1
公开(公告)日：2014-12-18
申请号：US14370633
申请日：2013-06-17
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yuji Kazuta , Toru Watanabe , Keiichi Sorimachi , Minako Saito , Yoichi Kita , Toshiaki Tanaka , Hiroyuki Higashiyama , Takahisa Hanada , Tetsuyuki Teramoto , Takashi Kosasa , Yukio Ishikawa
IPC: C07C307/08
CPC classification number: C07C307/08 , A61K31/18 , C07C309/00 , C07C2602/08
Abstract: Novel indansulfamide derivatives or a pharmaceutically acceptable salt thereof such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, have an action of improving Seizure Severity Index (Score) in mice kindling model. Thus the compounds or the salt thereof are expected as a drug for treating epilepsy.
Abstract translation: 新型的茚满磺酰胺衍生物或其药学上可接受的盐，例如N - [（1S）-2,2,5,7-四氟-2,3-二氢-1H-茚-1-基]磺酰胺，N - [（1S） -2,2,4,7-四氟-2,3-二氢-1H-茚-1-基]磺酰胺，（+） - N-（2,2,4,6,7-五氟-2,3- 二氢-1H-茚-1-基）磺酰胺，具有改善小鼠诱发模型中的发作严重程度指数（Score）的作用。 因此，期望化合物或其盐作为治疗癫痫的药物。
-
公开(公告)号：US09828336B2
公开(公告)日：2017-11-28
申请号：US15158687
申请日：2016-05-19
Applicant: Eisai R&D Management Co., Ltd.
Inventor： George Anthony Moniz , Annie Zhu Wilcoxen , Farid Benayoud , Toshiaki Tanaka , Keiichi Sorimachi
IPC: C07C309/73 , C07C303/44 , C07C309/66 , C07C69/16 , C12P7/22 , C07D401/12 , C07D239/34 , C07C303/28 , C07C29/147
CPC classification number: C07C309/73 , C07B2200/07 , C07C29/147 , C07C69/16 , C07C303/28 , C07C303/44 , C07C309/66 , C07C2601/02 , C07D239/34 , C07D401/12 , C12P7/22 , C07C33/50
Abstract: The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists.
-
6.发明申请METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF OREXIN-2 RECEPTOR ANTAGONISTS 审中-公开合成OREXIN-2受体拮抗剂的方法和化合物公开(公告)号：US20160318858A1
公开(公告)日：2016-11-03
申请号：US15158687
申请日：2016-05-19
Applicant: Eisai R&D Management Co., Ltd.
Inventor： George Anthony Moniz , Annie Zhu Wilcoxen , Farid Benayoud , Toshiaki Tanaka , Keiichi Sorimachi
IPC: C07C309/73 , C07C303/44 , C12P7/22 , C07C303/28
CPC classification number: C07C309/73 , C07B2200/07 , C07C29/147 , C07C69/16 , C07C303/28 , C07C303/44 , C07C309/66 , C07C2601/02 , C07D239/34 , C07D401/12 , C12P7/22 , C07C33/50
Abstract: The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists.
Abstract translation: 本公开提供了可用于制备可用作食欲素-2受体拮抗剂的化合物的化合物和方法。
-
公开(公告)号：US09018260B2
公开(公告)日：2015-04-28
申请号：US14370633
申请日：2013-06-17
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yuji Kazuta , Toru Watanabe , Keiichi Sorimachi , Minako Saito , Yoichi Kita , Toshiaki Tanaka , Hiroyuki Higashiyama , Takahisa Hanada , Tetsuyuki Teramoto , Takashi Kosasa , Yukio Ishikawa
IPC: A61K31/18 , C07C311/00 , C07C307/08 , C07C309/00
CPC classification number: C07C307/08 , A61K31/18 , C07C309/00 , C07C2602/08
Abstract: Novel indansulfamide derivatives or a pharmaceutically acceptable salt thereof such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, have an action of improving Seizure Severity Index (Score) in mice kindling model. Thus the compounds or the salt thereof are expected as a drug for treating epilepsy.
Abstract translation: 新型的茚满磺酰胺衍生物或其药学上可接受的盐，例如N - [（1S）-2,2,5,7-四氟-2,3-二氢-1H-茚-1-基]磺酰胺，N - [（1S） -2,2,4,7-四氟-2,3-二氢-1H-茚-1-基]磺酰胺，（+） - N-（2,2,4,6,7-五氟-2,3- 二氢-1H-茚-1-基）磺酰胺，具有改善小鼠诱发模型中的发作严重程度指数（Score）的作用。 因此，期望化合物或其盐作为治疗癫痫的药物。
-
-
-
-
-
-
Search Results
7
records
(took 0.021 seconds)
